Effect of Cymbopogon citratus on contact dermatitis
Phase 3
Completed
- Conditions
- Contact dermatitis.Irritant contact dermatitis
- Registration Number
- IRCT20190425043372N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients older than 18 years old
Patients who suffers from mild to moderate contact dermatitis according to EASI index
Exclusion Criteria
Patients who have used oral corticosteroides, 2 months before study
Patients who have used topical immunosuppressants 4 weeks before study
Pregnant women
Breastfeeding women
Patients who have contact dermatitis history to herbal formulations
Patients who have skin infections
Patients who have immunosuppressive diseases
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eczema score according to EASI. Timepoint: Measuring EASI index at first day of study (before using topical formulation), 28 and 56 days after using formulation. Method of measurement: Eczema Area and Severity Index (EASI).
- Secondary Outcome Measures
Name Time Method